Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Questions 1/17/08 ... ads, my question
1
Jan 17, 2008 03:12PM

Re: Questions 1/17/08 ... ads, my question

in response to by
posted on Jan 17, 2008 03:40PM

Has management devised a strategy (hedge) to protect shareholder value from potentially unfavorable judgements by the USPTO, Congress, and/or the courts that could limit the ability of TPL/PTSC to collect licensing revenue through the life of the portfolio? 

 

Thanks for supporting this effort.

Share
New Message
Please login to post a reply